← Leaderboards
Leonidas G Koniaris
University Of Rochester
$4,256,381
Attributed
$5,270,464
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $740.8K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,270,464 · 6
VA$0 · 1
By mechanism
R01$2,650,867 · 2
P01$1,333,397 · 1
R21$684,150 · 2
K08$602,050 · 1
I01$0 · 1
Top collaborators
- Teresa A Zimmers8 shared
Most similar at University Of Rochester
Same institution · by research overlap
- James V Sitzmann$1,970,305
- Richard E Waugh$11,805,785
- James L McGrath$7,223,694
- Thomas R Gaborski$4,640,521
- Britta Engelhardt$727,953
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionOperative Surgical ProceduresMolecularCachexiaMorbidity - Disease RateTissuesMuscleSignal TransductionMuscular AtrophyLiverInterleukin-6Skeletal MuscleMortalityBloodMalignant NeoplasmsMetabolicReportingInjuryWastingOrganPathway InteractionsCellsResponseCytokine
Grant awards (26)
Core B â Human Biospecimen and Advanced Sequencing Core$224,279
P01 · FY2025 · CA · contact PI
Yap1/TAZ and CD14 in the Catabolic Response to Sepsis$0
I01 · FY2025 · VA · contact PI
Core B â Human Biospecimen and Advanced Sequencing Core$210,973
P01 · FY2024 · CA · contact PI
Yap1/TAZ and CD14 in the Catabolic Response to Sepsis$0
I01 · FY2024 · VA · contact PI
The Musculoskeletal Cost of Organ Repair$384,518
R01 · FY2023 · GM · contact PI
Core B â Human Biospecimen and Advanced Sequencing Core$315,185
P01 · FY2023 · CA · contact PI
Core B â Human Biospecimen and Advanced Sequencing Core$316,362
P01 · FY2022 · CA · contact PI
The Musculoskeletal Cost of Organ Repair$311,931
R01 · FY2022 · GM · contact PI
The Musculoskeletal Cost of Organ Repair$112,546
R01 · FY2022 · GM · contact PI
The Musculoskeletal Cost of Organ Repair$414,221
R01 · FY2021 · GM · contact PI
Core B â Human Biospecimen and Advanced Sequencing Core$266,598
P01 · FY2021 · CA · contact PI
The Musculoskeletal Cost of Organ Repair$9,580
R01 · FY2021 · GM · contact PI
The Musculoskeletal Cost of Organ Repair$414,221
R01 · FY2020 · GM · contact PI
Morbidity, Mortality and Mechanisms of Persistent Muscle Wasting due to Abdominal Aortic Aneurysm-AAA Cachexia$173,250
R21 · FY2020 · AR
Morbidity, Mortality and Mechanisms of Persistent Muscle Wasting due to Abdominal Aortic Aneurysm-AAA Cachexia$207,900
R21 · FY2019 · AR
EGFR therapies for fatty liver surgery$339,300
R01 · FY2014 · DK · contact PI
EGFR therapies for fatty liver surgery$327,424
R01 · FY2013 · DK · contact PI
EGFR therapies for fatty liver surgery$1
R01 · FY2013 · DK · contact PI
EGFR therapies for fatty liver surgery$337,125
R01 · FY2012 · DK · contact PI
Increasing Functional Liver Mass in Health and Disease$151,500
R21 · FY2005 · DK
The Role of GDF-15 in Organ Injury$120,419
K08 · FY2005 · GM
Increasing Functional Liver Mass in Health and Disease$151,500
R21 · FY2004 · DK
The Role of GDF-15 in Organ Injury$121,205
K08 · FY2004 · GM
The Role of GDF-15 in Organ Injury$120,663
K08 · FY2003 · GM
The Role of GDF-15 in Organ Injury$120,137
K08 · FY2002 · GM
The Role of GDF-15 in Organ Injury$119,626
K08 · FY2001 · GM